Jim Cramer Advises His Viewers On Array Biopharma, GoPro & Sprint Corp

On CNBC's Mad Money, Jim Cramer said that Array Biopharma Inc ARRY is a very speculative stock and he would own something less speculative in the current market environment.

Cramer thinks that GoPro Inc GPRO was really good when it had a tight flow, but now he just wants to move onto a different trade.

Sprint Corp S won't move much higher in the near term, he said, because the government hasn't allowed a merger with T-Mobile US Inc TMUS.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!